Startup Genome
PrivateLast Round
Seed
Jun 28, 2016
Total Funding Raised
$4.7M
Company Overview
Startup Genome is a research and policy advisory firm that provides data-driven insights and strategic guidance to governments and innovation-focused organizations to accelerate the growth of startup ecosystems.
Sector
AI, Data & Cloud Infrastructure
Verticals
Business Intelligence, Financial Data, Data Visualization
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Startup Genome Comparables
Compare Startup Genome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StartupBlink | 88% | |
| Dealroom.co | 83% | |
| DEEP Ecosystems | 77% |
Startup Genome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 28, 2016 | ||||
| Seed | Oct 27, 2014 | ||||
| Seed | Dec 22, 2013 |
Startup Genome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Enterprise Associates (NEA) | Seed |
| Crosslink Capital | Seed |
| Streamlined Ventures | Seed |
| PROfounders Capital Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 28, 2016
$1M round with participation from NEA and PROfounders.
- Oct 27, 2014
$3M round with participation from NEA and Crosslink Capital.
Startup Genome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Startup Genome's valuation, stock price, and market status.
Is Startup Genome a public or private company?
Startup Genome is a private company.
What is the current stock price of Startup Genome?
Startup Genome is a private company with no public stock price. Caplight tracks Startup Genome's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Startup Genome worth (valuation)?
Valuation information for Startup Genome is not publicly available.
Can I buy Startup Genome stock?
Startup Genome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Startup Genome's last funding round?
Startup Genome's most recent funding round was Seed on June 28, 2016.
Who are the main investors in Startup Genome?
Key investors in Startup Genome include New Enterprise Associates (NEA), Crosslink Capital, Streamlined Ventures, PROfounders Capital Partners.
Will Startup Genome IPO soon?
No public IPO plans have been announced for Startup Genome.
How can I track Startup Genome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Startup Genome's secondary market activity and sign up for updates.